Provincial governments are concerned about making drug funding decisions in a fair and sustainable way. This includes priorities about which cancer drugs should be funded. These decisions are difficult, especially when a high price tag for a drug needs to be considered against what may often be small increases in health benefits. These decisions are even harder when other less expensive drugs may be available that may provide only slightly less health benefits.
Decisions about these types of trade-offs among potential benefits, harms and costs of a drug involve large investments of public resources. Since these investments are often made at the expense of other priorities, it is important for policymakers to have input from a wide range of people affected by the issue, including input in the form of the values and preferences of citizens.